IO Biotech (NASDAQ:IOBT – Free Report) had its price objective increased by HC Wainwright from $8.00 to $12.00 in a research report released on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for IO Biotech’s Q2 2024 earnings at ($0.31) EPS, Q3 2024 earnings at […]
IO Biotech (NASDAQ:IOBT) Price Target Raised to $12 00 at HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.